genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Genetic diseases
Artificial Intelligence
ASGCT 2024: Interview with Frédéric Revah, CEO of Généthon
Genome Editing
ASGCT 2024: David Liu Touts Rapid Evolution of Gene-Sized Programmable Editing Technologies
Drug Discovery
ASGCT 2024: SalioGen’s Nonviral In Vivo Gene Insertion Technology Takes Preclinical Strides
Genome Editing
ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress
Genome Editing
ASGCT 2024: Mammoth Sizes Up Genome Editing Opportunities
Drug Discovery
Boy Dosed with Pfizer DMD Gene Therapy Dies a Year after Phase II Trial
Drug Discovery
ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop
Drug Discovery
FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B
Bioprocessing
2025 Cell & Gene Therapy Reimbursement Outlook
GEN Edge
CRISPR Concerns Won’t Spoil Its Promise—If We Use the Right Tools
1
2
3
...
83
Page 1 of 83
Scroll Up